Actimab-A — Initial data
H2 2026–H1 2027
We expect to report initial data from this trial in 2H:2026 or 1H:2027.Source filing
ATNM biotech catalysts & pipeline
ACTINIUM PHARMACEUTICALS INC · Data as of 2026-09-08
Upcoming catalysts
Actimab-A — Initial data
Oct 2026–Dec 2027
We expect to report data from ongoing company- and investigator-sponsored clinical studies for ATNM-400, Actimab-A for MDSC's and Iomab-ACT in 4Q:2026 and over the course of 2027.Source filing
ATNM-400 — Initial data
Oct 2026–Dec 2027
We expect to report data from ongoing company- and investigator-sponsored clinical studies for ATNM-400, Actimab-A for MDSC's and Iomab-ACT in 4Q:2026 and over the course of 2027.Source filing
Iomab-ACT — Initial data
Oct 2026–Dec 2027
We expect to report data from ongoing company- and investigator-sponsored clinical studies for ATNM-400, Actimab-A for MDSC's and Iomab-ACT in 4Q:2026 and over the course of 2027.Source filing